Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patients with type 2 diabetes, hypertension, and renal disease in Switzerland
Gespeichert in:
Verfasser / Beitragende:
[A.J. Palmer, S. Roze, W.J. Valentine, J.A. Ray, A. Frei, M. Burnier, B. Hess, G.A. Spinas, M. Brändle]
Ort, Verlag, Jahr:
2006
Enthalten in:
Swiss medical weekly, 136/21-22(2006-05-27), 346-352
Format:
Artikel (online)